Plant-based expression and characterization of SARS-CoV-2 virus-like particles presenting a native spike protein

被引:30
|
作者
Jung, Jae-Wan [1 ,2 ]
Zahmanova, Gergana [3 ,4 ]
Minkov, Ivan [4 ,5 ]
Lomonossoff, George P. [1 ]
机构
[1] John Innes Ctr, Dept Biochem & Metab, Norwich Res Pk, Norwich, Norfolk, England
[2] Jeonbuk Natl Univ, Dept Mol Biol, Jeonju, South Korea
[3] Paisij Hilendarski Univ Plovdiv, Dept Plant Physiol & Mol Biol, Plovdiv, Bulgaria
[4] Ctr Plant Syst Biol & Biotechnol, Plovdiv, Bulgaria
[5] Inst Mol Biol & Biotechnol, Markovo, Bulgaria
基金
新加坡国家研究基金会; 英国生物技术与生命科学研究理事会;
关键词
severe acute respiratory syndrome coronavirus 2; virus-like particles; spike protein; COVID-19; Nicotiana benthamiana; transient expression; RESPIRATORY-SYNDROME CORONAVIRUS; INFECTIOUS-BRONCHITIS-VIRUS; STRUCTURAL PROTEINS; RAPID PRODUCTION; ENTRY; IMMUNOGENICITY; ANTIBODIES; SYSTEMS;
D O I
10.1111/pbi.13813
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have investigated the use of transient expression to produce virus-like particles (VLPs) of severe acute respiratory syndrome coronavirus 2, the causative agent of COVID-19, in Nicotiana benthamiana. Expression of a native form of the spike (S) protein, either alone or in combination with the envelope (E) and membrane (M) proteins, all of which were directed to the plant membranes via their native sequences, was assessed. The full-length S protein, together with degradation products, could be detected in total protein extracts from infiltrated leaves in both cases. Particles with a characteristic 'crown-shaped' or 'spiky' structure could be purified by density gradient centrifugation. Enzyme-linked immunosorbent assays using anti-S antibodies showed that threefold higher levels of VLPs containing the full-length S protein were obtained by infiltration with S alone, compared to co-infiltration of S with M and E. The S protein within the VLPs could be cleaved by furin in vitro and the particles showed reactivity with serum from recovering COVID-19 patients, but not with human serum taken before the pandemic. These studies show that the native S protein expressed in plants has biological properties similar to those of the parent virus. We show that the approach undertaken is suitable for the production of VLPs from emerging strains and we anticipate that the material will be suitable for functional studies of the S protein, including the assessment of the effects of specific mutations. As the plant-made material is noninfectious, it does not have to be handled under conditions of high containment.
引用
收藏
页码:1363 / 1372
页数:10
相关论文
共 50 条
  • [1] Construction of SARS-CoV-2 virus-like particles in plant
    Ki-Beom Moon
    Jae-Heung Jeon
    Hyukjun Choi
    Ji-Sun Park
    Su-Jin Park
    Hyo-Jun Lee
    Jeong Mee Park
    Hye Sun Cho
    Jae Sun Moon
    Hyunwoo Oh
    Sebyung Kang
    Hugh S. Mason
    Suk-Yoon Kwon
    Hyun-Soon Kim
    Scientific Reports, 12
  • [2] Construction of SARS-CoV-2 virus-like particles in plant
    Moon, Ki-Beom
    Jeon, Jae-Heung
    Choi, Hyukjun
    Park, Ji-Sun
    Park, Su-Jin
    Lee, Hyo-Jun
    Park, Jeong Mee
    Cho, Hye Sun
    Moon, Jae Sun
    Oh, Hyunwoo
    Kang, Sebyung
    Mason, Hugh S.
    Kwon, Suk-Yoon
    Kim, Hyun-Soon
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Characterization and discrimination of spike protein in SARS-CoV-2 virus-like particles via surface-enhanced Raman spectroscopy
    Akdeniz, Munevver
    Al-Shaebi, Zakarya
    Altunbek, Mine
    Bayraktar, Canan
    Kayabolen, Alisan
    Bagci-Onder, Tugba
    Aydin, Omer
    BIOTECHNOLOGY JOURNAL, 2024, 19 (01)
  • [4] Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
    Xu, Ruodan
    Shi, Mingfei
    Li, Jing
    Song, Ping
    Li, Ning
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
  • [5] Gold Nanoparticle Virus-like Particles Presenting SARS-CoV-2 Spike Protein: Synthesis, Biophysical Properties and Immunogenicity in BALB/c Mice
    Salazar, Vivian A.
    Comenge, Joan
    Suarez-Lopez, Rosa
    Burger, Judith A.
    Sanders, Rogier W.
    Bastus, Neus G.
    Jaime, Carlos
    Joseph-Munne, Joan
    Puntes, Victor
    VACCINES, 2024, 12 (08)
  • [6] A perspective on SARS-CoV-2 virus-like particles vaccines
    Gao, Xiaoyang
    Xia, Yeting
    Liu, Xiaofang
    Xu, Yinlan
    Lu, Pengyang
    Dong, Zhipeng
    Liu, Jing
    Liang, Gaofeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 115
  • [7] SARS-CoV-2 Virus-like Particles with Plasmonic Au Cores and S1-Spike Protein Coronas
    Andrzejewska, Weronika
    Peplinska, Barbara
    Litowczenko, Jagoda
    Obstarczyk, Patryk
    Olesiak-Banska, Joanna
    Jurga, Stefan
    Lewandowski, Mikolaj
    ACS SYNTHETIC BIOLOGY, 2023, 12 (08): : 2320 - 2328
  • [8] ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines
    Hoffmann, Magnus A. G.
    Yang, Zhi
    Huey-Tubman, Kathryn E.
    Cohen, Alexander A.
    Gnanapragasam, Priyanthi N. P.
    Nakatomi, Leesa M.
    Storm, Kaya N.
    Moon, Woohyun J.
    Lin, Paulo J. C.
    West Jr, Anthony P.
    Bjorkman, Pamela J.
    CELL, 2023, 186 (11) : 2380 - +
  • [9] Production of SARS-CoV-2 Virus-Like Particles in Insect Cells
    Mi, Youjun
    Xie, Tao
    Zhu, Bingdong
    Tan, Jiying
    Li, Xuefeng
    Luo, Yanping
    Li, Fei
    Niu, Hongxia
    Han, Jiangyuan
    Lv, Wei
    Wang, Juan
    VACCINES, 2021, 9 (06)
  • [10] The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles
    Boson, Bertrand
    Legros, Vincent
    Zhou, Bingjie
    Siret, Eglantine
    Mathieu, Cyrille
    Cosset, Francois-Loic
    Lavillette, Dimitri
    Denolly, Solene
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296